Previous 10 | Next 10 |
Poster highlights Phase 1 results following treatment with TSC-100 and TSC-101 after hematopoietic cell transplantation Company to host a virtual KOL event featuring Monzr M. Al Malki, M.D., to discuss highlights from the meeting and preliminary data today, Wednesday, May 17 th ...
2023-05-10 13:43:10 ET TScan Therapeutics press release ( NASDAQ: TCRX ): Q1 GAAP EPS of -$0.93 misses by $0.19 . Revenue of $6.81M (+125.5% Y/Y) beats by $2.51M . For further details see: TScan Therapeutics GAAP EPS of -$0.93 misses by $0.19, revenue of ...
2023-05-10 10:00:34 ET Gainers: CTI BioPharma ( CTIC ) +85% . Cano Health ( CANO ) +29% . TScan Therapeutics ( TCRX ) +24% . RxSight ( RXST ) +11% . Guardant Health ( GH ) +14% . Losers: Babylon Holdings ( BBLN ) -71...
2023-05-10 08:19:32 ET CTI BioPharma ( CTIC ) +84% to acquire CTI BioPharma for $9.10 per share. Upstart Holdings ( UPST ) +36% Q1 earnings call release Insignia Systems ( ISIG ) +27% Q1 earnings call release Microvast Holdings ( MVST ) +2...
Entered into partnership with Amgen to identify novel targets in Crohn’s disease; TScan to receive $30 million upfront Enrolled patients in all three arms of Phase 1 hematologic malignancies study; TSC-101 progressing to second dose level Announced upcoming trial-in-progr...
2023-05-10 06:00:00 ET Use These Strategies to Maximize Your Penny Stocks Profits Penny stocks, known for their affordability and potential for high returns, have captured the interest of many investors looking for opportunities to expand their portfolios. As the popularity of penny sto...
2023-05-09 13:22:40 ET Gainers: TScan Therapeutics ( TCRX ) +124% . Shengfeng Development Limited ( SFWL ) +102% . Mobiquity Technologies ( MOBQ ) +68% . ClearOne ( CLRO ) +62% . U.S. GoldMining ( USGOW ) +57% . Novavax ( N...
Tscan Therapeutics Inc (NASDAQ: TCRX) is one of today's top gainers. The company's shares are currently up 128.37% on the day to $4.91. TScan Therapeutics, Inc., a preclinical-stage biopharmaceutical company, focuses on developing a pipeline of T cell receptor-engineered T cell, or TCR-T, ther...
2023-05-09 10:09:59 ET TScan Therapeutics ( NASDAQ: TCRX ) added ~102% in the morning hours on Monday in reaction to a multi-year partnership with Amgen ( AMGN ) to identify therapeutic targets in the gastrointestinal disorder Crohn's disease. Per the terms, Amgen ( ...
2023-05-09 10:00:33 ET Gainers: TScan Therapeutics ( TCRX ) +151% . Ensysce Biosciences ( ENSC ) +60% . Novavax ( NVAX ) +36% . Y-mAbs Therapeutics ( YMAB ) +30% . Longeveron ( LGVN ) +26% . Losers: Enanta Pharmaceuti...
News, Short Squeeze, Breakout and More Instantly...
TScan Therapeutics Inc. Company Name:
TCRX Stock Symbol:
NYSE Market:
TScan Therapeutics Inc. Website:
2024-07-26 15:08:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-16 12:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-26 16:44:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...